Jongkundang Health's premium vitamin brand 'I'm Vita' announced that its multivitamin Immune Shot has surpassed 30 million bottles in cumulative sales just two years after its launch.
I'm Vita Immune Shot, first released in October 2022, gained market attention by selling 10 million bottles within one year. Since then, it has achieved sales of 30 million bottles in just two years as of October this year, receiving enthusiastic support from consumers.
I'm Vita Immune Shot is an all-in-one multivitamin with a dual formulation, allowing users to conveniently recharge their energy anytime and anywhere, making it an optimized product for the busy lifestyles of modern people.
The product contains up to 4000% of the daily nutritional value of vitamin B complex in a high concentration, uses 100% European vitamins from DSM, a company with 120 years of history, and is designed with an optimal blend of 18 nutrients, including 10 types of vitamins, 7 types of minerals, and beta-carotene.
I'm Vita Immune Shot solidified its position as a trusted brand among domestic consumers by being ranked first in the vitamin industry sector in the 26th Korea Brand Power Index (K-BPI) for 2024 announced earlier this year by the Korea Management Association Consulting (KMAC), and by winning the Innovation Best Practice category at the 2024 Korea Management Awards.
A representative from Jongkundang Health's I'm Vita stated, “I'm Vita Immune Shot has been greatly loved as a vitamin that revitalizes daily life tired from work and studies, achieving the record of 30 million bottles sold in a short period,” and added, “We are grateful for the support of many people.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.


